Anticoagulant Sodium Citrate and Insulin glulisine Subcutaneous
Determining the interaction of Anticoagulant Sodium Citrate and Insulin glulisine Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sodium citrate
Brand name:
Synonyms: n.a.
Generic Name: insulin glulisine
Brand name: Apidra, Apidra OptiClik Cartridge, Apidra SoloStar Pen
Synonyms: Insulin glulisine, Insulin Glulisine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anticoagulant Sodium Citrate-Insulin human inhaled Inhalation
- Anticoagulant Sodium Citrate-Insulin human regular Injection
- Anticoagulant Sodium Citrate-Insulin inhalation
- Anticoagulant Sodium Citrate-Insulin isophane
- Anticoagulant Sodium Citrate-Insulin isophane and insulin regular
- Anticoagulant Sodium Citrate-Insulin lispro
- Insulin glulisine Subcutaneous-Antiflex
- Insulin glulisine Subcutaneous-Antifungal
- Insulin glulisine Subcutaneous-Antihemophilic and von Willebrand factor complex
- Insulin glulisine Subcutaneous-Antihemophilic Factor (Recombinant [Fc Fusion Protein])
- Insulin glulisine Subcutaneous-Antihemophilic Factor (Recombinant [Pegylated-aucl])
- Insulin glulisine Subcutaneous-Antihemophilic Factor (Recombinant [Pegylated])